The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease
Authors:
- Ligia Maria ClaroLCLigia Maria Claro
- Andrea N. Moreno-AmaralAMAndrea N. Moreno-Amaral
- Ana Carolina GadottiAGAna Carolina Gadotti
- Carla J. DolengaCDCarla J. Dolenga
- Lia S. NakaoLNLia S. Nakao
- Marina L.V. AzevedoMAMarina L.V. Azevedo
- Lucia De NoronhaLNLucia De Noronha
- Marcia OlandoskiMOMarcia Olandoski
- Thyago P. De MoraesTMThyago P. De Moraes
- Andréa E. M. StinghenAndréa E. M. Stinghen
- Roberto Pécoits-FilhoRPRoberto Pécoits-Filho
Open Access
Abstract
Uremic toxin (UT) retention in chronic kidney disease (CKD) affects biological systems. We aimed to identify the associations between UT, inflammatory biomarkers and biomarkers of the uremic cardiovascular response (BUCVR) and their impact on cardiovascular status as well as their roles as predictors of outcome in CKD patients. CKD patients stages 3, 4 and 5 (n = 67) were recruited and UT (indoxyl sulfate/IS, p-cresil sulfate/pCS and indole-3-acetic acid/IAA); inflammatory biomarkers [Interleukin-6 (IL-6), high sensitivity C reactive protein (hsCRP), monocyte chemoattractant protein-1 (MCP-1), soluble vascular adhesion molecule-1 (sVCAM-1), soluble intercellular adhesion molecule-1 (sICAM-1) and soluble Fas (sFas)] and BUCVRs [soluble CD36 (sCD36), soluble receptor for advanced glycation end products (sRAGE), fractalkine] was measured. Patients were followed for 5.2 years and all causes of death was used as the primary outcome. Artery segments collected at the moment of transplantation were used for the immunohistochemistry analysis in a separate cohort. Estimated glomerular filtration rate (eGFR), circulating UT, plasma biomarkers of systemic and vascular inflammation and BUCVR were strongly interrelated. Patients with plaque presented higher signs of UT-induced inflammation and arteries from CKD patients presented higher fractalkine receptor (CX3CR1) tissue expression. Circulating IS (p = 0.03), pCS (p = 0.007), IL-6 (p = 0.026), sFas (p = 0.001), sCD36 (p = 0.01) and fractalkine (p = 0.02) were independent predictors of total mortality risk in CKD patients. Our results reinforce the important role of uremic toxicity in the pathogenesis of cardiovascular disease (CVD) in CKD patients through an inflammatory pathway.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (483632/2011-12)
- Fundação Araucária (202/2012 – 23715)
This publication has 38 references indexed in Scilit:
- Cardiovascular Burden Associated with Uremic Toxins in Patients with Chronic Kidney DiseaseAmerican Journal of Nephrology, 2013
- Fractalkine is an independent predictor of mortality in patients with advanced heart failureThrombosis and Haemostasis, 2012
- Fractalkine/CX3CR1 and atherosclerosisClinica Chimica Acta, 2011
- Vascular Incompetence in Dialysis Patients—Protein‐Bound Uremic Toxins and Endothelial DysfunctionSeminars in Dialysis, 2011
- Soluble Fas: a useful marker of inflammation and cardiovascular diseases in uremic patientsClinical and Experimental Nephrology, 2010
- Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease PatientsClinical Journal of the American Society of Nephrology, 2009
- Inflammatory Syndrome in Patients on HemodialysisJournal of the American Society of Nephrology, 2006
- IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the uglyKidney International, 2005
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- CD36 Induction on Human Monocytes upon Adhesion to Tumor Necrosis Factor-activated Endothelial CellsJournal of Biological Chemistry, 1995